ReP USP - Resultado da busca

Artigo de periodico
The role of CYP2C9*2, CYP2C9*3 and VKORC1-1639 variants on the susceptibility of upper gastrointestinal bleeding: a full case-control study (2023)
Forgerini, Marcela ; Urbano, Gustavo ; Nadai, Tales Rubens de ; Batah, Sabrina Setembre ; Fabro, Alexandre Todorovic ; Mastroianni, Patricia de Carvalho
Source: Journal of Pharmacy and Pharmaceutical Sciences. Unidades: FOB, FMRP, FM
Subjects: ANTI-INFLAMATÓRIOS NÃO ESTEROIDES, CITOCROMO P-450, ANTICOAGULANTES, AGREGAÇÃO PLAQUETÁRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FORGERINI, Marcela et al. The role of CYP2C9*2, CYP2C9*3 and VKORC1-1639 variants on the susceptibility of upper gastrointestinal bleeding: a full case-control study. Journal of Pharmacy and Pharmaceutical Sciences, v. 26, 2023Tradução . . Disponível em: https://doi.org/10.3389/jpps.2023.11136. Acesso em: 14 nov. 2024.
APA
Forgerini, M., Urbano, G., Nadai, T. R. de, Batah, S. S., Fabro, A. T., & Mastroianni, P. de C. (2023). The role of CYP2C9*2, CYP2C9*3 and VKORC1-1639 variants on the susceptibility of upper gastrointestinal bleeding: a full case-control study. Journal of Pharmacy and Pharmaceutical Sciences, 26. doi:10.3389/jpps.2023.11136
NLM
Forgerini M, Urbano G, Nadai TR de, Batah SS, Fabro AT, Mastroianni P de C. The role of CYP2C9*2, CYP2C9*3 and VKORC1-1639 variants on the susceptibility of upper gastrointestinal bleeding: a full case-control study [Internet]. Journal of Pharmacy and Pharmaceutical Sciences. 2023 ; 26[citado 2024 nov. 14 ] Available from: https://doi.org/10.3389/jpps.2023.11136
Vancouver
Forgerini M, Urbano G, Nadai TR de, Batah SS, Fabro AT, Mastroianni P de C. The role of CYP2C9*2, CYP2C9*3 and VKORC1-1639 variants on the susceptibility of upper gastrointestinal bleeding: a full case-control study [Internet]. Journal of Pharmacy and Pharmaceutical Sciences. 2023 ; 26[citado 2024 nov. 14 ] Available from: https://doi.org/10.3389/jpps.2023.11136
Artigo de periodico
Circulating plasma miRNA and clinical/hemodynamic characteristics provide additional predictive information about acute pulmonary thromboembolism, chronic thromboembolic pulmonary hypertension and idiopathic pulmonary hypertension (2021)
Fabro, Alexandre Todorovic ; Machado-Rugolo, Juliana ; Baldavira, Camila Machado ; Prieto, Tabatha Gutierrez ; Farhat, Cecilia; Mangone, Flavia Regina Rotea; Batah, Sabrina Setembre ; Cruvinel, Heloísa Resende; Alda, Maiara Almeida; Monteiro, Jhonatas Sirino ; Padua, Adriana Inácio de; Morais, Sirlei Siani; Oliveira, Rogério Antônio de ; Santos, Marcel Koenigkam ; Martinez, José Antônio Baddini ; Setubal, João Carlos ; Rainho, Cláudia Aparecida ; Yoo, Hugo Hyung Bok ; Silva, Pedro Leme; Nagai, Maria Aparecida ; Capelozzi, Vera Luiza
Source: Frontiers in Pharmacology. Unidades: FMRP, IQ, FM, BIOINFORMÁTICA
Subjects: MICRORNAS, SEQUENCIAMENTO GENÉTICO, PLASMA, HIPERTENSÃO PULMONAR, TROMBOEMBOLISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FABRO, Alexandre Todorovic et al. Circulating plasma miRNA and clinical/hemodynamic characteristics provide additional predictive information about acute pulmonary thromboembolism, chronic thromboembolic pulmonary hypertension and idiopathic pulmonary hypertension. Frontiers in Pharmacology, v. 12, p. 1-12 art. 648769, 2021Tradução . . Disponível em: https://doi.org/10.3389/fphar.2021.648769. Acesso em: 14 nov. 2024.
APA
Fabro, A. T., Machado-Rugolo, J., Baldavira, C. M., Prieto, T. G., Farhat, C., Mangone, F. R. R., et al. (2021). Circulating plasma miRNA and clinical/hemodynamic characteristics provide additional predictive information about acute pulmonary thromboembolism, chronic thromboembolic pulmonary hypertension and idiopathic pulmonary hypertension. Frontiers in Pharmacology, 12, 1-12 art. 648769. doi:10.3389/fphar.2021.648769
NLM
Fabro AT, Machado-Rugolo J, Baldavira CM, Prieto TG, Farhat C, Mangone FRR, Batah SS, Cruvinel HR, Alda M A, Monteiro JS, Padua AI de, Morais SS, Oliveira RA de, Santos MK, Martinez JAB, Setubal JC, Rainho CA, Yoo HHB, Silva PL, Nagai MA, Capelozzi VL. Circulating plasma miRNA and clinical/hemodynamic characteristics provide additional predictive information about acute pulmonary thromboembolism, chronic thromboembolic pulmonary hypertension and idiopathic pulmonary hypertension [Internet]. Frontiers in Pharmacology. 2021 ; 12 1-12 art. 648769.[citado 2024 nov. 14 ] Available from: https://doi.org/10.3389/fphar.2021.648769
Vancouver
Fabro AT, Machado-Rugolo J, Baldavira CM, Prieto TG, Farhat C, Mangone FRR, Batah SS, Cruvinel HR, Alda M A, Monteiro JS, Padua AI de, Morais SS, Oliveira RA de, Santos MK, Martinez JAB, Setubal JC, Rainho CA, Yoo HHB, Silva PL, Nagai MA, Capelozzi VL. Circulating plasma miRNA and clinical/hemodynamic characteristics provide additional predictive information about acute pulmonary thromboembolism, chronic thromboembolic pulmonary hypertension and idiopathic pulmonary hypertension [Internet]. Frontiers in Pharmacology. 2021 ; 12 1-12 art. 648769.[citado 2024 nov. 14 ] Available from: https://doi.org/10.3389/fphar.2021.648769
Artigo de periodico
Honeymoon period in newborn rats with CDH is associated with changes in the VEGF signaling pathway (2021)
Costa, Karina Miura da ; Fabro, Alexandre Todorovic; Becari, Christiane; Figueira, Rebeca Lopes; Schmidt, Augusto F.; Ruano, Rodrigo; Sbragia, Lourenço
Source: Frontiers in Pediatrics. Unidades: FMRP, FM
Subjects: HÉRNIA DIAFRAGMÁTICA ANIMAL, VASCULARIZAÇÃO EM ANIMAL, MALFORMAÇÕES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, Karina Miura da et al. Honeymoon period in newborn rats with CDH is associated with changes in the VEGF signaling pathway. Frontiers in Pediatrics, v. 9, 2021Tradução . . Disponível em: https://doi.org/10.3389/fped.2021.698217. Acesso em: 14 nov. 2024.
APA
Costa, K. M. da, Fabro, A. T., Becari, C., Figueira, R. L., Schmidt, A. F., Ruano, R., & Sbragia, L. (2021). Honeymoon period in newborn rats with CDH is associated with changes in the VEGF signaling pathway. Frontiers in Pediatrics, 9. doi:10.3389/fped.2021.698217
NLM
Costa KM da, Fabro AT, Becari C, Figueira RL, Schmidt AF, Ruano R, Sbragia L. Honeymoon period in newborn rats with CDH is associated with changes in the VEGF signaling pathway [Internet]. Frontiers in Pediatrics. 2021 ; 9[citado 2024 nov. 14 ] Available from: https://doi.org/10.3389/fped.2021.698217
Vancouver
Costa KM da, Fabro AT, Becari C, Figueira RL, Schmidt AF, Ruano R, Sbragia L. Honeymoon period in newborn rats with CDH is associated with changes in the VEGF signaling pathway [Internet]. Frontiers in Pediatrics. 2021 ; 9[citado 2024 nov. 14 ] Available from: https://doi.org/10.3389/fped.2021.698217
Artigo de periodico
In situ evidence of collagen V and interleukin-6/interleukin-17 activation in vascular remodeling of experimental pulmonary hypertension (2020)
Batah, Sabrina Setembre ; Alda, Maiara Almeida; Figueira, Rebeca Rodrigues Lopes Roslindo ; Cruvinel, Heloisa R.; Silva, Luis Perdoná Rodrigues da; Machado-rugolo, Juliana; Velosa, Ana Paula; Teodoro, Walcy Paganelli Rosolia ; Balancin, Marcelo Luiz ; Silva, Pedro Leme; Capelozzi, Vera Luiza ; Fabro, Alexandre Todorovic
Source: Pathobiology. Unidades: FM, FMRP, FSP
Subjects: IMUNOFLUORESCÊNCIA, COLÁGENO, INTERLEUCINA 6, HIPERTENSÃO PULMONAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BATAH, Sabrina Setembre et al. In situ evidence of collagen V and interleukin-6/interleukin-17 activation in vascular remodeling of experimental pulmonary hypertension. Pathobiology, v. 87, n. 6, p. 356-366, 2020Tradução . . Disponível em: https://doi.org/10.1159/000510048. Acesso em: 14 nov. 2024.
APA
Batah, S. S., Alda, M. A., Figueira, R. R. L. R., Cruvinel, H. R., Silva, L. P. R. da, Machado-rugolo, J., et al. (2020). In situ evidence of collagen V and interleukin-6/interleukin-17 activation in vascular remodeling of experimental pulmonary hypertension. Pathobiology, 87( 6), 356-366. doi:10.1159/000510048
NLM
Batah SS, Alda M A, Figueira RRLR, Cruvinel H R, Silva LP R da, Machado-rugolo J, Velosa A P, Teodoro WPR, Balancin ML, Silva P L, Capelozzi VL, Fabro AT. In situ evidence of collagen V and interleukin-6/interleukin-17 activation in vascular remodeling of experimental pulmonary hypertension [Internet]. Pathobiology. 2020 ; 87( 6): 356-366.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1159/000510048
Vancouver
Batah SS, Alda M A, Figueira RRLR, Cruvinel H R, Silva LP R da, Machado-rugolo J, Velosa A P, Teodoro WPR, Balancin ML, Silva P L, Capelozzi VL, Fabro AT. In situ evidence of collagen V and interleukin-6/interleukin-17 activation in vascular remodeling of experimental pulmonary hypertension [Internet]. Pathobiology. 2020 ; 87( 6): 356-366.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1159/000510048
Artigo de periodico
Intranasal administration of type V collagen reduces lung carcinogenesis through increasing endothelial apoptosis in a urethane-induced lung tumor model (2016)
Parra, Edwin Roger; Alveno, Renata Antunes; Faustino, Carolina Brito; Correa, Paula Yume Sata Serzedello; Vargas, Camila Mutai; Morais, Jymenez de; Rangel, Maristela Peres; Velosa, Ana Paula Pereira; Fabro, Alexandre Todorovic; Teodoro, Waley Rosolia; Capelozzi, Vera Luiza
Source: Archivum Immunologiae et Therapiae Experimentalis. Unidades: FMRP, FM
Subjects: APOPTOSE, COLÁGENO, CÉLULAS ENDOTELIAIS, CÉLULAS EPITELIAIS, NEOPLASIAS PULMONARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PARRA, Edwin Roger et al. Intranasal administration of type V collagen reduces lung carcinogenesis through increasing endothelial apoptosis in a urethane-induced lung tumor model. Archivum Immunologiae et Therapiae Experimentalis, v. 64, n. 4, p. 321-329, 2016Tradução . . Disponível em: https://doi.org/10.1007/s00005-016-0390-1. Acesso em: 14 nov. 2024.
APA
Parra, E. R., Alveno, R. A., Faustino, C. B., Correa, P. Y. S. S., Vargas, C. M., Morais, J. de, et al. (2016). Intranasal administration of type V collagen reduces lung carcinogenesis through increasing endothelial apoptosis in a urethane-induced lung tumor model. Archivum Immunologiae et Therapiae Experimentalis, 64( 4), 321-329. doi:10.1007/s00005-016-0390-1
NLM
Parra ER, Alveno RA, Faustino CB, Correa PYSS, Vargas CM, Morais J de, Rangel MP, Velosa APP, Fabro AT, Teodoro WR, Capelozzi VL. Intranasal administration of type V collagen reduces lung carcinogenesis through increasing endothelial apoptosis in a urethane-induced lung tumor model [Internet]. Archivum Immunologiae et Therapiae Experimentalis. 2016 ; 64( 4): 321-329.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1007/s00005-016-0390-1
Vancouver
Parra ER, Alveno RA, Faustino CB, Correa PYSS, Vargas CM, Morais J de, Rangel MP, Velosa APP, Fabro AT, Teodoro WR, Capelozzi VL. Intranasal administration of type V collagen reduces lung carcinogenesis through increasing endothelial apoptosis in a urethane-induced lung tumor model [Internet]. Archivum Immunologiae et Therapiae Experimentalis. 2016 ; 64( 4): 321-329.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1007/s00005-016-0390-1

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Subjects

Funding Agencies

Indexado em

Non normalized affiliation